Virios Therapeutics Llc Price History
VIRIDelisted Stock | USD 3.95 0.00 0.00% |
If you're considering investing in Virios Stock, it is important to understand the factors that can impact its price. As of today, the current price of Virios Therapeutics stands at 3.95, as last reported on the 26th of November, with the highest price reaching 4.10 and the lowest price hitting 3.64 during the day. Virios Therapeutics is dangerous at the moment. Virios Therapeutics Llc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0091, which indicates the firm had a 0.0091% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Virios Therapeutics Llc, which you can use to evaluate the volatility of the company. Please validate Virios Therapeutics' Coefficient Of Variation of (2,499), risk adjusted performance of (0.02), and Variance of 73.19 to confirm if the risk estimate we provide is consistent with the expected return of 0.0919%.
Virios Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Virios |
Sharpe Ratio = 0.0091
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | VIRI |
Negative Returns |
Estimated Market Risk
10.09 actual daily | 89 89% of assets are less volatile |
Expected Return
0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Virios Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virios Therapeutics by adding Virios Therapeutics to a well-diversified portfolio.
Virios Therapeutics Stock Price History Chart
There are several ways to analyze Virios Stock price data. The simplest method is using a basic Virios candlestick price chart, which shows Virios Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Virios Stock Price History Data
The price series of Virios Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 3.46 with a coefficient of variation of 13.91. The daily prices for the period are distributed with arithmetic mean of 4.67. The median price for the last 90 days is 4.68. The company experienced 1:25 stock split on 9th of October 2024.Open | High | Low | Close | Volume | ||
11/26/2024 | 3.95 | 4.10 | 3.64 | 3.95 | ||
10/21/2024 | 3.95 | 4.10 | 3.64 | 3.95 | 108,931 | |
10/18/2024 | 4.00 | 4.00 | 3.85 | 3.86 | 119,201 | |
10/17/2024 | 3.97 | 4.20 | 3.85 | 4.01 | 214,674 | |
10/16/2024 | 3.64 | 4.90 | 3.50 | 4.43 | 207,711 | |
10/15/2024 | 4.38 | 4.39 | 3.64 | 3.66 | 101,304 | |
10/14/2024 | 3.75 | 4.79 | 3.62 | 4.49 | 259,479 | |
10/11/2024 | 3.12 | 5.29 | 2.80 | 4.12 | 1,082,358 | |
10/10/2024 | 2.79 | 3.14 | 2.50 | 3.12 | 154,491 | |
10/09/2024 | 3.55 | 3.77 | 2.52 | 2.83 | 190,293 | |
10/08/2024 | 5.01 | 5.17 | 3.58 | 3.88 | 1,687,910 | |
10/07/2024 | 4.36 | 4.36 | 3.15 | 3.45 | 157,612 | |
10/04/2024 | 4.01 | 4.30 | 4.00 | 4.23 | 12,375 | |
10/03/2024 | 3.95 | 4.00 | 3.85 | 3.92 | 12,373 | |
10/02/2024 | 3.90 | 4.07 | 3.90 | 3.98 | 5,781 | |
10/01/2024 | 4.19 | 4.30 | 3.78 | 3.90 | 27,107 | |
09/30/2024 | 4.50 | 4.81 | 4.20 | 4.25 | 34,974 | |
09/27/2024 | 4.50 | 4.68 | 4.42 | 4.68 | 5,107 | |
09/26/2024 | 4.37 | 4.82 | 4.30 | 4.50 | 18,560 | |
09/25/2024 | 4.75 | 4.90 | 4.27 | 4.37 | 39,430 | |
09/24/2024 | 4.78 | 5.12 | 4.75 | 4.75 | 18,572 | |
09/23/2024 | 4.88 | 5.48 | 4.63 | 4.86 | 23,533 | |
09/20/2024 | 5.13 | 5.25 | 4.92 | 4.98 | 10,789 | |
09/19/2024 | 5.25 | 5.25 | 4.87 | 5.05 | 15,612 | |
09/18/2024 | 5.33 | 5.33 | 4.91 | 5.00 | 6,380 | |
09/17/2024 | 4.96 | 5.71 | 4.80 | 5.06 | 33,041 | |
09/16/2024 | 4.75 | 4.99 | 4.68 | 4.91 | 10,012 | |
09/13/2024 | 4.75 | 5.00 | 4.63 | 4.87 | 10,870 | |
09/12/2024 | 4.72 | 4.80 | 4.57 | 4.74 | 7,343 | |
09/11/2024 | 4.47 | 4.68 | 4.28 | 4.68 | 18,780 | |
09/10/2024 | 4.50 | 4.65 | 4.28 | 4.39 | 7,902 | |
09/09/2024 | 4.55 | 4.69 | 4.38 | 4.53 | 11,074 | |
09/06/2024 | 4.63 | 4.68 | 4.25 | 4.45 | 16,919 | |
09/05/2024 | 4.45 | 4.75 | 4.34 | 4.62 | 15,311 | |
09/04/2024 | 4.80 | 4.98 | 4.45 | 4.45 | 9,711 | |
09/03/2024 | 4.98 | 5.00 | 4.52 | 4.58 | 12,175 | |
08/30/2024 | 4.60 | 4.93 | 4.53 | 4.85 | 16,421 | |
08/29/2024 | 4.75 | 4.81 | 4.47 | 4.50 | 17,482 | |
08/28/2024 | 5.23 | 5.39 | 4.63 | 4.63 | 31,879 | |
08/27/2024 | 5.40 | 5.57 | 5.05 | 5.18 | 23,302 | |
08/26/2024 | 5.12 | 6.00 | 5.12 | 5.39 | 65,437 | |
08/23/2024 | 5.08 | 5.38 | 4.58 | 5.26 | 277,907 | |
08/22/2024 | 5.25 | 5.54 | 5.00 | 5.24 | 21,425 | |
08/21/2024 | 5.08 | 5.75 | 4.75 | 5.65 | 71,068 | |
08/20/2024 | 5.12 | 5.29 | 4.75 | 4.92 | 10,928 | |
08/19/2024 | 4.93 | 4.94 | 4.51 | 4.75 | 8,190 | |
08/16/2024 | 4.82 | 4.82 | 4.50 | 4.72 | 6,067 | |
08/15/2024 | 4.28 | 4.87 | 4.28 | 4.72 | 7,047 | |
08/14/2024 | 4.58 | 4.58 | 4.25 | 4.39 | 5,916 | |
08/13/2024 | 4.35 | 4.50 | 4.18 | 4.49 | 7,266 | |
08/12/2024 | 4.43 | 4.44 | 4.05 | 4.18 | 15,188 | |
08/09/2024 | 4.66 | 4.66 | 4.35 | 4.36 | 9,995 | |
08/08/2024 | 4.75 | 4.75 | 4.14 | 4.48 | 33,045 | |
08/07/2024 | 4.91 | 4.91 | 4.55 | 4.68 | 12,045 | |
08/06/2024 | 4.67 | 5.00 | 4.67 | 4.86 | 10,151 | |
08/05/2024 | 4.52 | 4.75 | 4.25 | 4.64 | 15,295 | |
08/02/2024 | 5.10 | 5.12 | 4.32 | 4.72 | 37,492 | |
08/01/2024 | 5.25 | 5.40 | 5.01 | 5.15 | 29,363 | |
07/31/2024 | 5.28 | 5.36 | 5.20 | 5.28 | 9,131 | |
07/30/2024 | 5.50 | 5.50 | 5.13 | 5.26 | 22,098 | |
07/29/2024 | 5.61 | 5.61 | 5.06 | 5.48 | 33,135 |
About Virios Therapeutics Stock history
Virios Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Virios is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Virios Therapeutics Llc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Virios Therapeutics stock prices may prove useful in developing a viable investing in Virios Therapeutics
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia. Virios Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Virios Therapeutics Stock Technical Analysis
Virios Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Virios Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Virios Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Virios Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Virios to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.32) | |||
Total Risk Alpha | (1.70) | |||
Treynor Ratio | 1.2 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |